Flindr Labs
1014.117.578 · rovalta.com · 24/09/2026
Flindr Labs
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOFlindr Labs is a Private limited company incorporated in 2024. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Gent. It employs on average 4,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1014.117.578
- Incorporation
- 25/09/2024
- Legal form
- Private limited company
- Registered office
- Technologiepark-Zwijnaarde 94
9052 Gent · FlandreSee on map - Contributed capital
- 200 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 4,2 ETP
Joint committees (1)
- 20700
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | 294,8 k € |
| EBITDA | -194,6 k € |
| Operating result | -602,6 k € |
| Net result | -591,1 k € |
| Balance sheet | |
| Equity | -391,1 k € |
| Total assets | 262,9 k € |
| Cash | 39,3 k € |
| Debts | 593,3 k € |
| Other | |
| Workforce | 4,2 ETP |
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Technologiepark-Zwijnaarde 94 9052 Gent| Company | CBE no. |
|---|---|
AnimAb● Active | 0747.674.614 |
BioLyo Technologies● Active | 0741.579.648 |
ExeVir Bio● Active | 0750.495.334 |
Protealis● Active | 0765.251.410 |
| 0873.953.667 | |
Zomagen Biosciences Belgium● Active | 0744.519.837 |
Financials
Full financial information
Source · NBB| 2025 | |
|---|---|
| Type of account | Abridged model |
| Start of the financial year | 25/09/2024 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 16 months |
| Filing date | 23/06/2026 |
| General meeting | 15/06/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 15/06/2026 | 23/06/2026 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-591,1 k €
- 25/09/2024IncorporationPrivate limited company